Identifying urotropine derivatives as co-donors of formaldehyde and nitric oxide for improving antitumor therapy

The first co-donor of formaldehyde and nitric oxide (FANO) was synthesized via pharmacophore integration strategy, which simultaneously generated NO and formaldehyde on-demand, resulting in synergistic anticancer effects both in vitro and in vivo.